CWM
RVMD icon

CIBC World Markets’s Revolution Medicines RVMD Stock Holding History

CIBC World Markets’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37,786
Closed -$1.34M – 1868
2025
Q1 		$1.34M Buy
37,786
+22,122
+141% +$898K 0.01% 601
2024
Q4 		$685K Buy
+15,664
New +$791K ﹤0.01% 665

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CIBC World Markets's RVMD Position: Q2 2025 in Review

CIBC World Markets sold out of Revolution Medicines (RVMD) in Q2 2025, closing a stake of 37,786 shares — an estimated $1.34M sold.

CIBC World Markets first reported a position in RVMD in Q4 2024 and held it in 2 quarters. The position peaked at $1.34M in Q1 2025. 307 funds tracked by Wall St. Rank hold RVMD as of Q2 2025.

  • CIBC World Markets reported no remaining Revolution Medicines position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 37,786 Revolution Medicines shares in Q2 2025, an estimated $1.34M.
  • CIBC World Markets first reported a position in Revolution Medicines in Q4 2024 and held it in 2 quarters.
  • CIBC World Markets's Revolution Medicines position peaked at $1.34M in Q1 2025.
  • 307 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.